Lee’s Pharmaceutical Holdings Limited (HK:0950) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Lee’s Pharmaceutical Holdings Limited has announced the issuance of 1,764,000 share options under its Share Option Scheme on June 20, 2024, with an exercise price set at HK$1.200 per share. The options, which have a market value of around HK$2.116 million based on the current share price, will have a vesting period extending from June 2025 to December 2025 and are exercisable until June 2034.
For further insights into HK:0950 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue